Literature DB >> 17241534

Influence of silybin on biophysical properties of phospholipid bilayers.

Olga Wesołowska1, Barbara Łania-Pietrzak, Micha Kuzdzał, Kamila Stanczak, Daniela Mosiadz, Piotr Dobryszycki, Andrzej Ozyhar, Małgorzata Komorowska, Andrzej B Hendrich, Krystyna Michalak.   

Abstract

AIM: Silybin (silibinin) is major biologically active flavonolignan extracted from milk thistle (Sylibum marianum). Its biological activities include hepato-protection, anticancer properties, and antioxidant- and membrane-stabilizing functions. Although membranes are postulated to be one of the cellular targets for silybin, little is known about its interaction with phospholipid bilayers.
METHODS: In the present work, the interactions of silybin with phosphatidylcholine bilayers were studied in detail using fluorescence spectroscopy, microcalorimetry and electron spin resonance techniques.
RESULTS: The results showed that silybin interacted with the surface of lipid bilayers. It affected the generalized polarization of the fluorescent probe Prodan, while not influencing the more deeply located Laurdan. Silybin lowered the main phospholipid phase transition temperature as judged by microcalorimetry, and caused the immobilization of spin probe Tempo-palmitate located on the surface of membranes. The mobility of spin probes 5- and 16-doxyl stearic acid was not affected by silybin. Silybin-induced quenching of 1,6-diphenyl-1,3,5-hexatriene fluorescence indicated that some flavonoid molecules partitioned into the hydrophobic region of membranes, which did not change significantly the biophysical properties of the deeper membrane regions.
CONCLUSION: Such a behavior of silybin in membranes is in accordance with its postulated biological functions and neglectable side effects of therapies using silybin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17241534     DOI: 10.1111/j.1745-7254.2007.00487.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  9 in total

1.  Analysis of hepatitis C virus resistance to silibinin in vitro and in vivo points to a novel mechanism involving nonstructural protein 4B.

Authors:  Katharina Esser-Nobis; Inés Romero-Brey; Tom M Ganten; Jérôme Gouttenoire; Christian Harak; Rahel Klein; Peter Schemmer; Marco Binder; Paul Schnitzler; Darius Moradpour; Ralf Bartenschlager; Stephen J Polyak; Wolfgang Stremmel; François Penin; Christoph Eisenbach; Volker Lohmann
Journal:  Hepatology       Date:  2013-02-07       Impact factor: 17.425

2.  Free radical scavenging activity of silibinin in nitrite-induced hemoglobin oxidation and membrane fragility models.

Authors:  Bushra H Marouf; Munaf H Zalzala; Ihab I Al-Khalifa; Tavga A Aziz; Saad A Hussain
Journal:  Saudi Pharm J       Date:  2011-03-21       Impact factor: 4.330

3.  Prediction of CYP-mediated silybin A-losartan pharmacokinetic interactions using physiological based pharmacokinetic modeling.

Authors:  Ayesha Tanveer; Khalid Hussain; Hirra Tasneem; Iqra Arif; Memoona Rashid; Nasir Abbas; Rahat Shamim; Pervaiz A Shah; Nadeem Irfan Bukhari
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-01-21       Impact factor: 2.745

4.  Silymarin nanoparticle prevents paracetamol-induced hepatotoxicity.

Authors:  Suvadra Das; Partha Roy; Runa Ghosh Auddy; Arup Mukherjee
Journal:  Int J Nanomedicine       Date:  2011-06-22

Review 5.  Silybin, a Major Bioactive Component of Milk Thistle (Silybum marianum L. Gaernt.)-Chemistry, Bioavailability, and Metabolism.

Authors:  Michal Bijak
Journal:  Molecules       Date:  2017-11-10       Impact factor: 4.411

6.  Antiparasitic Effects of Selected Isoflavones on Flatworms.

Authors:  D Faixová; G Hrčková; T Mačák Kubašková; D Mudroňová
Journal:  Helminthologia       Date:  2021-02-10       Impact factor: 1.184

7.  The protective effect of silybin against lasalocid cytotoxic exposure on chicken and rat cell lines.

Authors:  Lidia Radko; Wojciech Cybulski; Wojciech Rzeski
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

8.  Flavonolignans inhibit the arachidonic acid pathway in blood platelets.

Authors:  Michal Bijak; Joanna Saluk-Bijak
Journal:  BMC Complement Altern Med       Date:  2017-08-10       Impact factor: 4.782

9.  PEG-Modified tert-Octylcalix[8]arenes as Drug Delivery Nanocarriers of Silibinin.

Authors:  Desislava Budurova; Denitsa Momekova; Georgi Momekov; Pavletta Shestakova; Hristo Penchev; Stanislav Rangelov
Journal:  Pharmaceutics       Date:  2021-11-27       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.